Ceritinib

Description

Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceritinib. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Ceritinib — ANDA 211225 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211225

Tags

  • drug-safety
  • public-health
  • prescription-drugs
  • drug
  • medications

Topics

Categories